Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural killer cell-mediated immunosurveillance of human cancer
Karl‐Johan Malmberg, Mattias Carlsten, Andreas T. Björklund, et al.
Seminars in Immunology (2017) Vol. 31, pp. 20-29
Closed Access | Times Cited: 258

Showing 1-25 of 258 citing articles:

NK cells for cancer immunotherapy
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 973
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu, Jonathan J. Hodgins, Malvika Marathe, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4654-4668
Open Access | Times Cited: 668
Natural killer cells in antitumour adoptive cell immunotherapy
Tamara Laskowski, Alexander Biederstädt, Katayoun Rezvani
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 557-575
Open Access | Times Cited: 482
Tumor-Infiltrating Natural Killer Cells
Beatriz Cózar, Marco Greppi, Sabrina Carpentier, et al.
Cancer Discovery (2020) Vol. 11, Iss. 1, pp. 34-44
Open Access | Times Cited: 356
Metal Drugs and the Anticancer Immune Response
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 307
Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression
Jingjing Cong, Xianwei Wang, Xiaohu Zheng, et al.
Cell Metabolism (2018) Vol. 28, Iss. 2, pp. 243-255.e5
Open Access | Times Cited: 293
NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing
Isabel Prager, Clarissa Liesche, Hanna van Ooijen, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 9, pp. 2113-2127
Open Access | Times Cited: 292
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 281
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
Tristan Courau, Julie Bonnereau, Justine Chicoteau, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 205
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
May Daher, Katayoun Rezvani
Current Opinion in Immunology (2018) Vol. 51, pp. 146-153
Open Access | Times Cited: 189
Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer
May Daher, Katayoun Rezvani
Cancer Discovery (2020) Vol. 11, Iss. 1, pp. 45-58
Open Access | Times Cited: 173
CAR‐NK cell in cancer immunotherapy; A promising frontier
Faroogh Marofi, Omar F. Abdul‐Rasheed, Heshu Sulaiman Rahman, et al.
Cancer Science (2021) Vol. 112, Iss. 9, pp. 3427-3436
Open Access | Times Cited: 122
Allogeneic natural killer cell therapy
Melissa M. Berrien-Elliott, Miriam T. Jacobs, Todd A. Fehniger
Blood (2022) Vol. 141, Iss. 8, pp. 856-868
Open Access | Times Cited: 114
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
Benjamin Ruf, Tim F. Greten, Firouzeh Korangy
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 351-371
Closed Access | Times Cited: 52
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 48
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Beibei Zhang, Mengzhe Yang, Weimin Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 18
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T. Björklund, Mattias Carlsten, Ebba Sohlberg, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 8, pp. 1834-1844
Open Access | Times Cited: 158
Natural killer cells in inflammation and autoimmunity
Béatrice Zitti, Yenan T. Bryceson
Cytokine & Growth Factor Reviews (2018) Vol. 42, pp. 37-46
Closed Access | Times Cited: 135
Natural Killer Cells in Cancer Immunotherapy
Jeffrey S. Miller, Lewis L. Lanier
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 77-103
Open Access | Times Cited: 133
Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells
Mattias Carlsten, Marcus Järås
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 125
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies
Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez
Seminars in Cancer Biology (2019) Vol. 72, pp. 76-89
Closed Access | Times Cited: 118
Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer–Mediated Cytotoxicity
Antoun Al Absi, Hannah Wurzer, Coralie L. Guérin, et al.
Cancer Research (2018) Vol. 78, Iss. 19, pp. 5631-5643
Open Access | Times Cited: 117
Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
Aviad Ben‐Shmuel, Guy Biber, Mira Barda‐Saad
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 117
Natural killer cell education in human health and disease
Jeanette E. Boudreau, Katharine C. Hsu
Current Opinion in Immunology (2018) Vol. 50, pp. 102-111
Open Access | Times Cited: 115
Page 1 - Next Page

Scroll to top